Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Ilan Ganot
|
| gptkbp:focusesOn |
gptkb:Duchenne_muscular_dystrophy
rare diseases gene therapy |
| gptkbp:foundedIn |
2013
|
| gptkbp:founder |
gptkb:Matthew_Arnold
Annie Ganot Ilan Ganot |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Solid Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:mission |
develop transformative treatments for patients with Duchenne muscular dystrophy and other neuromuscular diseases
|
| gptkbp:products |
SGT-001
SGT-003 |
| gptkbp:stockSymbol |
SLDB
|
| gptkbp:website |
https://www.solidbio.com/
|
| gptkbp:bfsParent |
gptkb:Andrey_Zarur
|
| gptkbp:bfsLayer |
7
|